Business Wire

Predator-Series Aircraft Pass Five Million Flight Hour Mark

Jaa

General Atomics Aeronautical Systems, Inc. (GA-ASI) today announced that its Predator®-series family of Remotely Piloted Aircraft (RPA), encompassing Predator, Predator B, Gray Eagle, and Avenger® lines, has achieved a historic industry milestone: five million flight hours. The milestone was achieved on April 4, with 360,311 total missions completed and more than 90 percent of all missions flown in combat.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180409006205/en/

“Five million flight hours is a testament to the reliability of our RPA systems that are designed, b ...

“Five million flight hours is a testament to the reliability of our RPA systems that are designed, built, and maintained by a dedicated group of skilled and innovative professionals for operations around the world,” said Linden Blue, CEO, GA-ASI. (Photo: Business Wire)

“Five million flight hours is a testament to the reliability of our RPA systems that are designed, built, and maintained by a dedicated group of skilled and innovative professionals for operations around the world,” said Linden Blue, CEO, GA-ASI. “Our 25-year history has produced a list of ‘firsts’ in RPA development and we have leveraged this progress to apply the latest technology and advancement in our new and improved aircraft, such as the MQ-9B SkyGuardian.”

The identification of the specific aircraft and customer that achieved the milestone is unknown as every second of every day, 69 Predator-class Medium-altitude, Long-endurance aircraft are airborne worldwide. Flight hours have continued to grow at unprecedented rates in recent years, with 500,000 flight hours achieved from 1993 to 2008, one million hours in 2010, two million hours in 2012, three million hours in 2014, and four million hours in 2016.

“The demand for persistent situational awareness using GA-ASI RPA is demonstrated daily through the increasing accumulation of flight hours. This demand is consistently answered by our team of employees, suppliers, and partners who work hard to meet our customers’ dynamic mission requirements,” said David R. Alexander, president, Aircraft Systems, GA-ASI.

Recently GA-ASI’s Predator B/MQ-9 Reaper fleet passed its own historic milestone, achieving two million flight hours on November 12, 2017 after flying approximately 143,279 total sorties. Predator B/MQ-9 Reaper flight hours now account for approximately 40 percent of GA-ASI’s five million total flight hours and are increasing at an average rate of 37,000 hours a month.

GA-ASI has more than 8,000 employees with 1135 employees and subcontractors deployed worldwide. On average, GA-ASI produces approximately eight aircraft per month.

GA-ASI aircraft average over 50,000 hours per month supporting the U.S. Air Force, U.S. Army, U.S. Department of Homeland Security, NASA, the Italian Air Force, the Royal Air Force, the French Air Force, the UAE Armed Forces, and other customers. Missions include helping protect ground units on the battlefield; supporting U.S. Customs & Border Protection operations, and first responders in the wake of natural disasters. These aircraft systems continue to maintain the highest operational availability rates in the U.S. Air Force and U.S. Army aircraft inventories. GA-ASI has produced more than 825 aircraft to date and over 300 Ground Control Stations (GCS).

The Predator-series family includes Predator A and Predator XP; Predator B/MQ-9B Reaper, Guardian, Predator B/MQ-9B Reaper Extended Range (ER), MQ-9B SkyGuardian, and SeaGuardian; Gray Eagle/ER; and Predator C Avenger/ER.

High-resolution photos of Predator-series aircraft are available to qualified media outlets from the listed GA-ASI media contact.

About GA-ASI

General Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable Remotely Piloted Aircraft (RPA) systems, radars, and electro-optic and related mission systems, including the Predator® RPA series and the Lynx® Multi-mode Radar. With more than 5 million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent flight that enables situational awareness and rapid strike. The company also produces a variety of ground control stations and sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas. For more information, visit www.ga-asi.com.

Predator, Avenger, Reaper, and Lynx are registered trademarks and SkyGuardian is a trademark of General Atomics Aeronautical Systems, Inc.

Contact information

General Atomics Aeronautical Systems, Inc.
Melissa Haynes
+1 (858) 524-8108
ASI-MediaRelations@ga-asi.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Workiva Named Best-In-Class Cloud Service Provider at UK Cloud Awards17.5.2019 15:00:00 EESTTiedote

Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, was named the Best-In-Class Cloud Service Provider by the UK Cloud Awards 2019 at a ceremony here last night. Now in its sixth year, the UK Cloud Awards recognise innovation and excellence in the cloud industry by showcasing leading companies, customers and individuals in the United Kingdom. Workiva was recognised for its Wdesk platform that helps organisations consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders. Workiva, the global leader in XBRL and Inline XBRL, is also streamlining how customers comply with the European Securities and Markets Authority's mandate for Inline XBRL for European Single Electronic Format (ESEF) reporting. More than 5,000 EU issuers will be required to use ESEF taxonomy for their annual financial reports, ending on or after Jan

Novaremed Presents Top-Line Results from Phase 2a Diabetic Neuropathic Pain Study of NRD.E1 at NeuPSIG 201917.5.2019 13:13:00 EESTTiedote

Novaremed AG, a clinical-stage Swiss biopharmaceutical company, today announced a poster presentation highlighting the top-line results from a Phase 2a (Proof of Concept) study of NRD.E1 for the treatment of diabetic neuropathic pain (DNP). The poster presentation took place at the 7th International Congress on Neuropathic Pain Meeting (NeuPSIG) in London, UK on May 9-11, 2019. “This was our first communication at a leading neuropathic pain-focused event. Novaremed’s lead drug, NRD.E1 is a non-opioid small molecule for the treatment of neuropathic pain. The results of our Phase 2a in patients with DNP showed clinically relevant treatment benefit from NRD.E1 across multiple primary and secondary endpoints, providing a strong scientific foundation for advancing the development of NRD.E1 into the upcoming global Phase 2b study in DNP,” said Sara Mangialaio, Head of R&D and Chief Medical Officer of Novaremed AG. “NRD.E1 has the potential to address a major unmet medical need in DNP.” Poste

WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology17.5.2019 12:38:00 EESTTiedote

The 11th WIN Symposium in Precision Oncology will be held in Paris, France on June 23-24, 2019. ASCO® endorsed for the past 11 years, the WIN symposium will deliver an exciting line-up of speakers in Paris (France) on June 23-24, 2019 to discuss Innovation and Global Deployment of Precision Oncology. The current status of Precision Oncology across the globe will be examined with the exceptional participation of the chairmen of the event, Richard L. Schilsky, Chairman WIN Consortium(*), Senior Vice-President and Chief Medical Officer of ASCO, and Josep Tabernero, Vice Chairman WIN Consortium, President of ESMO and Director of Vall d’Hebron Institute of Oncology, Spain. Global experience will be shared: Optimizing Patient Enrollment and Efficacy of Precision Oncology Clinical Trials at UT MD Anderson Cancer Center, USA Decision Support for Precision Oncology: Evolving from Monotherapy to Genomically Informed Combinations, UT MD Anderson Cancer Center, USA The Value of Personalized Medici

Corsearch Acquires Principium Trademark Watch and Domain Services Businesses17.5.2019 11:00:00 EESTTiedote

Corsearch, the global brand creation, clearance, and protection leader, is pleased to announce the acquisition of the Principium Strategies trademark watch and domain services businesses, the brand protection subsidiary of Ladas and Parry LLP, a leader in global intellectual property law. The acquisition is effective immediately, solidifying and expanding Corsearch’s full-service trademark solutions offering for clients and brands globally. Principium is Corsearch’s third acquisition since becoming a standalone company in January 2018. The acquisition brings Corsearch’s employee count to more than 350 operating in 28 locations worldwide and adds valuable industry expertise and additional capabilities to Corsearch. “This is another really exciting acquisition for our business and a step forward in the evolution of Corsearch,” said Stephen Stolfi, Chief Commercial Officer of Corsearch. “Principium has provided clients with industry-leading trademark watching services for over 80 years an

CNT Among SAP’s "Best of the Best"17.5.2019 11:00:00 EESTTiedote

Since 2005, SAP is honoring the best of the best SAP projects yearly in Europe, Middle East and Africa. In 2018, 280 customers from 15 markets submitted their regional Gold Award-winning projects. CNT Management Consulting from Vienna won Bronze twice – together with its customers HOERBIGER and TANNPAPIER – a happy day for CNT’s CEO Andreas Doerner. "We are now on the podium for the second time with two projects – thanks to the trust of our customers." The SAP Quality Awards EMEA were presented at an exceptionally festive ceremony in Heidelberg Castle (Baden-Wuerttemberg), and only twelve SAP customers were able to take home the most wanted trophies that were presented by SAP Presidents Brian Duffy (EMEA North) and Hartmut Thomsen (Middle and Eastern Europe). The jury evaluated the projects according to the ten SAP quality principles and the question of whether the respective project could fulfill the expectations of its clients. HOERBIGER - Category Business Transformation Headquarter

EVER Pharma acquires Amneal Deutschland GmbH and extends its commercial presence in Europe17.5.2019 10:25:00 EESTTiedote

EVER Pharma Holding Ges.m.b.H (Austria) announced today that it has completed the acquisition of Amneal Deutschland GmbH, a subsidiary of Amneal Pharmaceuticals that operates the company's commercial operations in Germany. Amneal Deutschland already distributes several EVER Pharma products in Germany and is a strongly established player in the German hospital market. The acquired entity will be rebranded to EVER Pharma GmbH. “This acquisition represents another milestone in the expansion of EVER Pharma’s commercial footprint in Europe. With this new operation, EVER Pharma extends its portfolio in Germany and establishes a solid platform for the growth of its portfolio and pipeline” commented Georges Kahwati, General Manager of EVER Pharma. “We are pleased to establish another EVER affiliate in one of the key European markets in line with our strategy of establishing our own business presence in core markets.” added Julia Hillebrand, Managing Director and Owner. About EVER Pharma: EVER

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme